-
1
-
-
84864477617
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803–869.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 803-869
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Bohm, M.5
Dickstein, K.6
Falk, V.7
Filippatos, G.8
Fonseca, C.9
Gomez-Sanchez, M.A.10
Jaarsma, T.11
Kober, L.12
Lip, G.Y.13
Maggioni, A.P.14
Parkhomenko, A.15
Pieske, B.M.16
Popescu, B.A.17
Ronnevik, P.K.18
Rutten, F.H.19
Schwitter, J.20
Seferovic, P.21
Stepinska, J.22
Trindade, P.T.23
Voors, A.A.24
Zannad, F.25
Zeiher, A.26
Bax, J.J.27
Baumgartner, H.28
Ceconi, C.29
Dean, V.30
Deaton, C.31
Fagard, R.32
Funck-Brentano, C.33
Hasdai, D.34
Hoes, A.35
Kirchhof, P.36
Knuuti, J.37
Kolh, P.38
McDonagh, T.39
Moulin, C.40
Reiner, Z.41
Sechtem, U.42
Sirnes, P.A.43
Tendera, M.44
Torbicki, A.45
Vahanian, A.46
Windecker, S.47
Bonet, L.A.48
Avraamides, P.49
Ben Lamin, H.A.50
Brignole, M.51
Coca, A.52
Cowburn, P.53
Dargie, H.54
Elliott, P.55
Flachskampf, F.A.56
Guida, G.F.57
Hardman, S.58
Iung, B.59
Merkely, B.60
Mueller, C.61
Nanas, J.N.62
Nielsen, O.W.63
Orn, S.64
Parissis, J.T.65
Ponikowski, P.66
more..
-
2
-
-
84922569400
-
A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction
-
Verloop WL, Beeftink MM, Santema BT, Bots ML, Blankestijn PJ, Cramer MJ, Doevendans PA, Voskuil M. A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction. PLoS One 2015;10:e0117332.
-
(2015)
PLoS One
, vol.10
-
-
Verloop, W.L.1
Beeftink, M.M.2
Santema, B.T.3
Bots, M.L.4
Blankestijn, P.J.5
Cramer, M.J.6
Doevendans, P.A.7
Voskuil, M.8
-
3
-
-
0037032384
-
Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure
-
Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288:2144–2150.
-
(2002)
JAMA
, vol.288
, pp. 2144-2150
-
-
Kitzman, D.W.1
Little, W.C.2
Brubaker, P.H.3
Anderson, R.T.4
Hundley, W.G.5
Marburger, C.T.6
Brosnihan, B.7
Morgan, T.M.8
Stewart, K.P.9
-
4
-
-
79961173816
-
Impairment of autonomic reactivity is a feature of heart failure whether or not the left ventricular ejection fraction is normal
-
Patel H, Ozdemir BA, Patel M, Xiao HB, Poole-Wilson PA, Rosen SD. Impairment of autonomic reactivity is a feature of heart failure whether or not the left ventricular ejection fraction is normal. Int J Cardiol 2011;151:34–39.
-
(2011)
Int J Cardiol
, vol.151
, pp. 34-39
-
-
Patel, H.1
Ozdemir, B.A.2
Patel, M.3
Xiao, H.B.4
Poole-Wilson, P.A.5
Rosen, S.D.6
-
5
-
-
1542401899
-
Heart rate variability and diastolic heart failure. Pacing and clinical electrophysiology
-
Arora R, Krummerman A, Vijayaraman P, Rosengarten M, Suryadevara V, Lejemtel T, Ferrick KJ. Heart rate variability and diastolic heart failure. Pacing and clinical electrophysiology. Pacing Clin Electrophysiol 2004;27:299–303.
-
(2004)
Pacing Clin Electrophysiol
, vol.27
, pp. 299-303
-
-
Arora, R.1
Krummerman, A.2
Vijayaraman, P.3
Rosengarten, M.4
Suryadevara, V.5
Lejemtel, T.6
Ferrick, K.J.7
-
6
-
-
0344942642
-
Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure
-
Vinch CS, Aurigemma GP, Hill JC, Gaasch WH, Volturo G, Tighe DA, Meyer TE. Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. Am J Cardiol 2003;91:1140–1143.
-
(2003)
Am J Cardiol
, vol.91
, pp. 1140-1143
-
-
Vinch, C.S.1
Aurigemma, G.P.2
Hill, J.C.3
Gaasch, W.H.4
Volturo, G.5
Tighe, D.A.6
Meyer, T.E.7
-
7
-
-
84939642930
-
The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction
-
Floras JS, Ponikowski P. The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur Heart J 2015;36:1974–1982.
-
(2015)
Eur Heart J
, vol.36
, pp. 1974-1982
-
-
Floras, J.S.1
Ponikowski, P.2
-
8
-
-
84878839685
-
High muscle sympathetic nerve activity is associated with left ventricular dysfunction in treated hypertensive patients
-
de Souza SB, Rocha JA, Cuoco MA, Guerra GM, Ferreira-Filho JC, Borile S, Krieger EM, Bortolotto LA, Consolim-Colombo FM. High muscle sympathetic nerve activity is associated with left ventricular dysfunction in treated hypertensive patients. Am J Hypertens 2013;26:912–917.
-
(2013)
Am J Hypertens
, vol.26
, pp. 912-917
-
-
de Souza, S.B.1
Rocha, J.A.2
Cuoco, M.A.3
Guerra, G.M.4
Ferreira-Filho, J.C.5
Borile, S.6
Krieger, E.M.7
Bortolotto, L.A.8
Consolim-Colombo, F.M.9
-
9
-
-
33750445618
-
The relationship between variables of 123-I-metaiodobenzylguanidine cardiac imaging and clinical status of the patients with diastolic heart failure
-
Sugiura M, Yamamoto K, Takeda Y, Takeda Y, Dohmori T, Ogata M, Kondo H, Suzuki S, Fukutomi T. The relationship between variables of 123-I-metaiodobenzylguanidine cardiac imaging and clinical status of the patients with diastolic heart failure. Int J Cardiol 2006;113:223–228.
-
(2006)
Int J Cardiol
, vol.113
, pp. 223-228
-
-
Sugiura, M.1
Yamamoto, K.2
Takeda, Y.3
Takeda, Y.4
Dohmori, T.5
Ogata, M.6
Kondo, H.7
Suzuki, S.8
Fukutomi, T.9
-
10
-
-
84899583609
-
The biophysics of renal sympathetic denervation using radiofrequency energy
-
Patel H, Dhillon P, Mahfoud F, Lindsay A, Hayward C, Ernst S, Lyon A, Rosen S, Di Mario C. The biophysics of renal sympathetic denervation using radiofrequency energy. Clin Res Cardiol 2014;103:337–344.
-
(2014)
Clin Res Cardiol
, vol.103
, pp. 337-344
-
-
Patel, H.1
Dhillon, P.2
Mahfoud, F.3
Lindsay, A.4
Hayward, C.5
Ernst, S.6
Lyon, A.7
Rosen, S.8
Di Mario, C.9
-
11
-
-
84901982262
-
Renal denervation and heart failure
-
Bohm M, Ewen S, Kindermann I, Linz D, Ukena C, Mahfoud F. Renal denervation and heart failure. Eur J Heart Fail 2014;16:608–613.
-
(2014)
Eur J Heart Fail
, vol.16
, pp. 608-613
-
-
Bohm, M.1
Ewen, S.2
Kindermann, I.3
Linz, D.4
Ukena, C.5
Mahfoud, F.6
-
12
-
-
84872500794
-
First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study
-
Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, Hamady M, Hughes AD, Sever PS, Sobotka PA, Francis DP. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol 2013;162:189–192.
-
(2013)
Int J Cardiol
, vol.162
, pp. 189-192
-
-
Davies, J.E.1
Manisty, C.H.2
Petraco, R.3
Barron, A.J.4
Unsworth, B.5
Mayet, J.6
Hamady, M.7
Hughes, A.D.8
Sever, P.S.9
Sobotka, P.A.10
Francis, D.P.11
-
13
-
-
84857773847
-
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension
-
Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Bohm M, Hoppe UC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012;59:901–909.
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 901-909
-
-
Brandt, M.C.1
Mahfoud, F.2
Reda, S.3
Schirmer, S.H.4
Erdmann, E.5
Bohm, M.6
Hoppe, U.C.7
-
14
-
-
79961032369
-
2+-ATPase in patients with advanced heart failure
-
2+-ATPase in patients with advanced heart failure. Circulation 2011;124:304–313.
-
(2011)
Circulation
, vol.124
, pp. 304-313
-
-
Jessup, M.1
Greenberg, B.2
Mancini, D.3
Cappola, T.4
Pauly, D.F.5
Jaski, B.6
Yaroshinsky, A.7
Zsebo, K.M.8
Dittrich, H.9
Hajjar, R.J.10
-
15
-
-
84876268473
-
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN)
-
Hare JM, Bolli R, Cooke JP, Gordon DJ, Henry TD, Perin EC, March KL, Murphy MP, Pepine CJ, Simari RD, Skarlatos SI, Traverse JH, Willerson JT, Szady AD, Taylor DA, Vojvodic RW, Yang PC, Moye LA. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation 2013;127:1630–1635.
-
(2013)
Circulation
, vol.127
, pp. 1630-1635
-
-
Hare, J.M.1
Bolli, R.2
Cooke, J.P.3
Gordon, D.J.4
Henry, T.D.5
Perin, E.C.6
March, K.L.7
Murphy, M.P.8
Pepine, C.J.9
Simari, R.D.10
Skarlatos, S.I.11
Traverse, J.H.12
Willerson, J.T.13
Szady, A.D.14
Taylor, D.A.15
Vojvodic, R.W.16
Yang, P.C.17
Moye, L.A.18
-
16
-
-
73649130995
-
Cardiac sympathetic imaging with mIBG in heart failure
-
Carrio I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging 2010;3:92–100.
-
(2010)
JACC Cardiovasc Imaging
, vol.3
, pp. 92-100
-
-
Carrio, I.1
Cowie, M.R.2
Yamazaki, J.3
Udelson, J.4
Camici, P.G.5
-
17
-
-
80054771951
-
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF
-
Davison BA, Cotter G, Sun H, Chen L, Teerlink JR, Metra M, Felker GM, Voors AA, Ponikowski P, Filippatos G, Greenberg B, Teichman SL, Unemori E, Koch GG. Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF. Clin Res Cardiol 2011;100:745–753.
-
(2011)
Clin Res Cardiol
, vol.100
, pp. 745-753
-
-
Davison, B.A.1
Cotter, G.2
Sun, H.3
Chen, L.4
Teerlink, J.R.5
Metra, M.6
Felker, G.M.7
Voors, A.A.8
Ponikowski, P.9
Filippatos, G.10
Greenberg, B.11
Teichman, S.L.12
Unemori, E.13
Koch, G.G.14
-
18
-
-
80054768603
-
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study
-
Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, Binder L, Topper A, Lashki DJ, Schwarz S, Herrmann-Lingen C, Loffler M, Hasenfuss G, Halle M, Pieske B. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 2011;58:1780–1791.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 1780-1791
-
-
Edelmann, F.1
Gelbrich, G.2
Dungen, H.D.3
Frohling, S.4
Wachter, R.5
Stahrenberg, R.6
Binder, L.7
Topper, A.8
Lashki, D.J.9
Schwarz, S.10
Herrmann-Lingen, C.11
Loffler, M.12
Hasenfuss, G.13
Halle, M.14
Pieske, B.15
-
19
-
-
84874367056
-
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial
-
Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Loffler M, Dungen HD, Tschope C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 2013;309:781–791.
-
(2013)
JAMA
, vol.309
, pp. 781-791
-
-
Edelmann, F.1
Wachter, R.2
Schmidt, A.G.3
Kraigher-Krainer, E.4
Colantonio, C.5
Kamke, W.6
Duvinage, A.7
Stahrenberg, R.8
Durstewitz, K.9
Loffler, M.10
Dungen, H.D.11
Tschope, C.12
Herrmann-Lingen, C.13
Halle, M.14
Hasenfuss, G.15
Gelbrich, G.16
Pieske, B.17
-
20
-
-
77951222477
-
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study
-
Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212–2221.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2212-2221
-
-
Jacobson, A.F.1
Senior, R.2
Cerqueira, M.D.3
Wong, N.D.4
Thomas, G.S.5
Lopez, V.A.6
Agostini, D.7
Weiland, F.8
Chandna, H.9
Narula, J.10
-
21
-
-
0035180535
-
Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study
-
Ogita H, Shimonagata T, Fukunami M, Kumagai K, Yamada T, Asano Y, Hirata A, Asai M, Kusuoka H, Hori M, Hoki N. Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart 2001;86:656–660.
-
(2001)
Heart
, vol.86
, pp. 656-660
-
-
Ogita, H.1
Shimonagata, T.2
Fukunami, M.3
Kumagai, K.4
Yamada, T.5
Asano, Y.6
Hirata, A.7
Asai, M.8
Kusuoka, H.9
Hori, M.10
Hoki, N.11
-
22
-
-
84903769517
-
Heart failure with preserved ejection fraction: the impact of stricter definitions
-
Patel HC, Hayward C, Di Mario C, Cowie MR, Lyon AR, Rosen SD. Heart failure with preserved ejection fraction: the impact of stricter definitions. Eur J Heart Fail 2014;16:767–771.
-
(2014)
Eur J Heart Fail
, vol.16
, pp. 767-771
-
-
Patel, H.C.1
Hayward, C.2
Di Mario, C.3
Cowie, M.R.4
Lyon, A.R.5
Rosen, S.D.6
-
23
-
-
84924426046
-
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
-
Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O'Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 2015;36:219–227.
-
(2015)
Eur Heart J
, vol.36
, pp. 219-227
-
-
Kandzari, D.E.1
Bhatt, D.L.2
Brar, S.3
Devireddy, C.M.4
Esler, M.5
Fahy, M.6
Flack, J.M.7
Katzen, B.T.8
Lea, J.9
Lee, D.P.10
Leon, M.B.11
Ma, A.12
Massaro, J.13
Mauri, L.14
Oparil, S.15
O'Neill, W.W.16
Patel, M.R.17
Rocha-Singh, K.18
Sobotka, P.A.19
Svetkey, L.20
Townsend, R.R.21
Bakris, G.L.22
more..
-
24
-
-
84905981330
-
Anatomic assessment of sympathetic peri-arterial renal nerves in man
-
Sakakura K, Ladich E, Cheng Q, Otsuka F, Yahagi K, Fowler DR, Kolodgie FD, Virmani R, Joner M. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol 2014;64:635–643.
-
(2014)
J Am Coll Cardiol
, vol.64
, pp. 635-643
-
-
Sakakura, K.1
Ladich, E.2
Cheng, Q.3
Otsuka, F.4
Yahagi, K.5
Fowler, D.R.6
Kolodgie, F.D.7
Virmani, R.8
Joner, M.9
-
25
-
-
84938532870
-
A cross-sectional imaging study to identify organs at risk of thermal injury during renal artery sympathetic denervation
-
Patel HC, Otero S, Moser JB, Hayward C, Rosen SD, Lyon AR, Mohiaddin R, Di Mario C, Padley S. A cross-sectional imaging study to identify organs at risk of thermal injury during renal artery sympathetic denervation. Int J Cardiol 2015;197:235–240.
-
(2015)
Int J Cardiol
, vol.197
, pp. 235-240
-
-
Patel, H.C.1
Otero, S.2
Moser, J.B.3
Hayward, C.4
Rosen, S.D.5
Lyon, A.R.6
Mohiaddin, R.7
Di Mario, C.8
Padley, S.9
-
26
-
-
84921567556
-
Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation
-
Patel HC, Hayward C, Ozdemir BA, Rosen SD, Krum H, Lyon AR, Francis DP, Di Mario C. Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation. Hypertension 2015;65:401–406.
-
(2015)
Hypertension
, vol.65
, pp. 401-406
-
-
Patel, H.C.1
Hayward, C.2
Ozdemir, B.A.3
Rosen, S.D.4
Krum, H.5
Lyon, A.R.6
Francis, D.P.7
Di Mario, C.8
-
27
-
-
84921598910
-
Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep
-
Booth LC, Nishi EE, Yao ST, Ramchandra R, Lambert GW, Schlaich MP, May CN. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension 2015;65:393–400.
-
(2015)
Hypertension
, vol.65
, pp. 393-400
-
-
Booth, L.C.1
Nishi, E.E.2
Yao, S.T.3
Ramchandra, R.4
Lambert, G.W.5
Schlaich, M.P.6
May, C.N.7
-
28
-
-
84878148445
-
Renal denervation for refractory hypertension – technical aspects, complications and radiation exposure
-
Scheurig-Muenkler C, Weiss W, Foert E, Toelle M, van der Giet M, Kroncke TJ, Zidek W, Powerski MJ. Renal denervation for refractory hypertension – technical aspects, complications and radiation exposure. Rofo 2013;185:550–557.
-
(2013)
Rofo
, vol.185
, pp. 550-557
-
-
Scheurig-Muenkler, C.1
Weiss, W.2
Foert, E.3
Toelle, M.4
van der Giet, M.5
Kroncke, T.J.6
Zidek, W.7
Powerski, M.J.8
-
29
-
-
84885025341
-
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document
-
Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Pina IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail 2013;15:1082–1094.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1082-1094
-
-
Zannad, F.1
Garcia, A.A.2
Anker, S.D.3
Armstrong, P.W.4
Calvo, G.5
Cleland, J.G.6
Cohn, J.N.7
Dickstein, K.8
Domanski, M.J.9
Ekman, I.10
Filippatos, G.S.11
Gheorghiade, M.12
Hernandez, A.F.13
Jaarsma, T.14
Koglin, J.15
Konstam, M.16
Kupfer, S.17
Maggioni, A.P.18
Mebazaa, A.19
Metra, M.20
Nowack, C.21
Pieske, B.22
Pina, I.L.23
Pocock, S.J.24
Ponikowski, P.25
Rosano, G.26
Ruilope, L.M.27
Ruschitzka, F.28
Severin, T.29
Solomon, S.30
Stein, K.31
Stockbridge, N.L.32
Stough, W.G.33
Swedberg, K.34
Tavazzi, L.35
Voors, A.A.36
Wasserman, S.M.37
Woehrle, H.38
Zalewski, A.39
McMurray, J.J.40
more..
|